There’s a common knowledge in the stock market: if a dividend yield looks unusually high, it must come with equally high risk. And in many cases, that suspicion is justified. When a company’s share ...

Turn $25,000 into monthly passive income! Discover how a single TSX ETF, a TFSA, and a DRIP can build a bulletproof portfolio ...

While Nifty Pharma giants struggle with regulatory headwinds and pricing pressures, two outliers are quietly catching the ...

Citi has initiated coverage on newly listed Orkla India, the company behind MTR foods and Eastern spices, with a Buy rating ...

MUMBAI: PhonePe, the Walmart-owned digital payments platform that accounts for nearly half of India’s UPI transaction volumes ...

Berkshire Hathaway’s new CEO Greg Abel used his first letter to shareholders to spotlight a smaller set of long-term equity ...

Mark Cuban says a low-cost S&P 500 fund should form the core of your portfolio. Here's why he favors index investing over stock picking and speculation.

Berkshire Hathaway's latest annual letter highlights why investors might want to hold on to the tech giant's stock for the long haul.

A balanced portfolio, say 50-60% equity, 25-30% debt, 10-15% precious metals, reduces portfolio beta and smoothens return trajectories ...

Fund believes bank turnaround specialist Gubin’s big success at Optimum could be a blueprint for a new Carver. Fund ...

Pier Capital sold 504,958 shares of Core Scientific in the fourth quarter. The shares were worth $9.06 million as of the last-disclosed position value. The position was previously 1.4% of the fund’s ...